Patents by Inventor Nassireddin Mokarram-Dorri

Nassireddin Mokarram-Dorri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240016774
    Abstract: The present technology relates to implantable depots for the local, sustained, controlled release of a therapeutic agent to treat cancer. An implantable depot may comprise a biodegradable polymer mixed with a locally acting chemotherapeutic agent. The depot may be configured to be implanted within a patient proximate cancerous tissue and, while implanted, provide sustained exposure of the chemotherapeutic agent at the treatment site.
    Type: Application
    Filed: October 14, 2021
    Publication date: January 18, 2024
    Inventors: Steven Kim, Karun D. Naga, Hanson S. Gifford, III, James Su, Nassireddin Mokarram-Dorri, Mark Deem, Stephen W. Boyd, Koon Kiat Teu, Wei Li Lee, Darryl Lim Wi Chung, Edward D. Gifford
  • Publication number: 20220183963
    Abstract: The present technology relates to implantable depots for the local, sustained, controlled release of a therapeutic agent to treat cancer. An implantable depot may comprise a biodegradable polymer mixed with a locally-acting therapeutic agent configured to treat cancer. The depot may be configured to be implanted within a patient proximate cancerous tissue and, while implanted, provide sustained exposure of the therapeutic agent at the treatment site for a period of time that is no less than 5 days.
    Type: Application
    Filed: April 11, 2020
    Publication date: June 16, 2022
    Inventors: Steven Kim, Karun D. Naga, Hanson S. Gifford, III, James Su, Nassireddin Mokarram-Dorri, Mark Deem, Stephen W. Boyd, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang, Edward D. Gifford
  • Publication number: 20220183964
    Abstract: The present technology relates to depots for the treatment of select symptoms via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising the therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for an extended period of time.
    Type: Application
    Filed: April 11, 2020
    Publication date: June 16, 2022
    Inventors: Karun D. Naga, Hanson S. Gifford, III, Mark Deem, Stephen W. Boyd, Nassireddin Mokarram-Dorri, Koon Kiat Teu, Daniel Boon Lim Seet, Wei Li Lee, Honglei Wang
  • Publication number: 20210069101
    Abstract: The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising a therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.
    Type: Application
    Filed: April 11, 2019
    Publication date: March 11, 2021
    Inventors: Karun D. Naga, Hanson S. Gifford, III, Stephen W. Boyd, Patrick H. Ruane, Jackie Joe Hancock, Michael Feldstein, Koon Kiat Teu, Honglei Wang, Jingnan Luo, Daniel Boon Lim Seet, Wei Li Lee, Nassireddin Mokarram-Dorri